Toshitaka Yukishima - Publications

Author response to the letter to the editor regarding "Hip Response to Romosozumab in Glucocorticoid Users: Beyond Systemic Bone Turnover Markers".

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: June 05, 2026

Efficacy of Switching from oral to Subcutaneous Methotrexate in Alleviating Methotrexate-related Intolerance Symptoms in Japanese Patients with Rheumatoid Arthritis: The METOJECTIVE Study.

Journal: Internal medicine (Tokyo, Japan)

Published: May 24, 2026

Correction: MRI-guided muscle biopsy improves diagnostic yield in small- to medium-vessel vasculitis: a retrospective single-center study.

Journal: Rheumatology international

Published: March 12, 2026

Impact of oral glucocorticoids on the effectiveness of romosozumab: the multicenter OASIS cohort study.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: February 19, 2026

Author response to letter to the editor, "PINP-guided osteoporosis treatment selection: methodological considerations for cut-off, endpoint, fracture confounding and teriparatide heterogeneity".

Journal: Bone

Published: November 09, 2025

Author response to letter to the editor, "Comment on "Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study"".

Journal: Bone

Published: October 27, 2025

MRI-guided muscle biopsy improves diagnostic yield in small- to medium-vessel vasculitis: a retrospective single-center study.

Journal: Rheumatology international

Published: September 29, 2025

Serum presepsin level reflects macrophage activation and hemophagocytosis in bone marrow.

Journal: PloS one

Published: August 28, 2025

Effectiveness of denosumab, teriparatide and romosozumab for glucocorticoid-induced osteoporosis: a propensity score-matched cohort study.

Journal: Rheumatology (Oxford, England)

Published: August 22, 2025

Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study.

Journal: Bone

Published: June 20, 2025

Author response to letter to the editor, (OSIN-D-25-00227) "From bisphosphonates to advanced therapies: a critical review of osteoporosis treatment strategies".

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: February 27, 2025

Successful glucocorticoid treatment case for IgG4-related long-standing optic neuropathy.

Journal: Modern rheumatology case reports

Published: January 16, 2025